Fried, Frank, Harris, Shriver & Jacobson advised LumiraDx Group Limited on the sale of its point of care technology unit to Roche Group for $350 million. The Fried Frank team was led by corporate partner Ian Lopez. Counsel information was not available for the Roche Group.
Biotech & Pharmaceuticals
January 03, 2024, 11:55 AM